Furthermore, REXO-C/ANP/S NPs, acting as a nano-scavenger, showed less α-syn expression level (red fluorescence) than other groups (Figure 5e), suggesting the superior ability of REXO-C/ANP/S NPs to clear α-syn aggregates for efficient AD therapy. This evidence concerns the gene NPPA and Alzheimer disease.